NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/14/2023
Back to search
Official data from USPTO
BASECAMP
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
03/14/2023
Trademark type
Word
Nice classes
42
Filing date
01/27/2022
Registration date
03/14/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/14/2023
Last transaction
03/14/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
05/13/2019
First use in commerce
05/13/2019
Drawing code
4
Owner type
03
Owner location
Cambridge, MA
Examiner
REGAN, BRENDAN
Law office
M40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
ElevateBio, LLC
Representatives
Maury M. Tepper, III TEPPER & EYSTER, PLLC
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research services; Research and development in the pharmaceutical and biotechnology fields; Research and development of new products; Research and development of vaccines and medicines; Research and development services in the field of antibodies; Researchdevelopmentengineering and testing services in the fields of immunopharmaceuticals and vaccines; Biochemical research and development; Conducting early evaluations in the field of new pharmaceuticals; Consulting services in the fields of biotechnologypharmaceutical research and developmentpharmacogenetics; Consulting services in the fields of biotechnologypharmaceutical research and development and genetic science; Development of pharmaceutical preparations and medicines; Laboratory research services relating to pharmaceuticals; Medical and scientific research in the field of cancer treatment and diagnosis; Medical research services in the field of cancer; Pharmaceutical research and development; Product research and development; Providing laboratory research services in the field of gene expressioncancer biology; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Providing medical testing services and information in the field of cancer research and disease classification; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Scientific research and development; Scientific research for medical purposes in the area of cancerous diseases; Technical consulting in the field of pharmaceutical studies; Technical research in the field of pharmaceutical studies; Testing of pharmaceuticals; Testinginspectionresearchdevelopment of pharmaceutical preparations for gene therapy
Publications
History of USPTO decisions and trademark events.
25 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
03/14/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02/07/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/06/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
01/09/2023
IUAF
USE AMENDMENT FILED
01/04/2023
EISU
TEAS STATEMENT OF USE RECEIVED
01/04/2023
NOAC
CORRECTED NOA E-MAILED
10/13/2022
ICNA
NOTICE OF ALLOWANCE CORRECTION ENTERED
10/12/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/12/2022
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
09/23/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09/20/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/26/2022
PUBO
PUBLISHED FOR OPPOSITION
07/26/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/06/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/23/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/02/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/02/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/02/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/11/2022
GNRT
NON-FINAL ACTION E-MAILED
05/11/2022
CNRT
NON-FINAL ACTION WRITTEN
05/11/2022
DOCK
ASSIGNED TO EXAMINER
05/09/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/01/2022
NWAP
NEW APPLICATION ENTERED
01/31/2022
Continuous trademark protection
Get notified about every new filing that threatens BASECAMP or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.